Universal Biosensors surges 60% on FDA approval for Class II device
Universal Biosensors shares surged 60% following the attainment of US Food and Drug Administration and Clinical Laboratory Improvement Amendments Waiver approvals.
Corporate Spotlight
Not Yet Available
Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.
Latest Threads
Tag | Subject | ||||||
---|---|---|---|---|---|---|---|
BGP | Ann: BGP - Lapse of Performance Rights | 15/03/24 | 0 | 70 | |||
|
|||||||
BGP | Ann: Application for quotation of securities - BGP | 15/03/24 | 0 | 90 | |||
|
|||||||
BGP | Ann: Capital Change Notice Filed with NZX | 15/03/24 | 0 | 90 | |||
|
|||||||
BGP | Ann: Dividend/Distribution - BGP | 13/03/24 | 0 | 98 | |||
|
|||||||
BGP | Ann: BGP Full Year to 28 January 2024 Addendum to Results | 13/03/24 | 0 | 91 | |||
|
|||||||
BGP | Ann: BGP Full Year to 28 January 2024 Results Announcement | 13/03/24 | 0 | 102 | |||
|
|||||||
BGP | Ann: BGP Director Nomination Closing Date | 01/03/24 | 0 | 102 | |||
|
|||||||
BGP | Ann: BGP Full Year Sales to 28 January 2024 | 02/02/24 | 0 | 131 | |||
|
See All Discussions
Timeline
|
|||||
|
|||||
|
|||||
|
|||||
|
|||||
|
|||||
View More |